Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: admitted forcardiac catheterisation major surgical or invasive procedure: cardiac catheterization with with drug eluting stent to the left main coronary artery. history of present illness: 89 year old female with pmh hyperlipidemia, s/p des 3.0x 23 mm in distal left main with impella, ostial 80% occluded successfully ptca and ptca rca (90% occluded), who presented from cath lab due to impaired hemostasis at left femoral entry after perclose device deployment. . following the closure she continued to bleed from her left groin and direct pressure was applied for 45 minutes continuously; after 45 minutes pressure was released and vigorous bleeding continued; pressure was again applied for 1 hour, however bleeding continued after pressure was released. patient has remained hemodynamically stable with no significant change in her hematocrit. . prior to this catherization and initially presented with the following symptoms at a total knee placment pre surgical workup. she c/o tightness in her chest and shortness of breath at times which had been going on constantly for approximately 2 months, not better or worse with anything inparticular, including exercise. she states that the pressure sometimes comes on worse in the middle of the night. it radiates to the l shoulder, is not associated with n/v/d. . upon reaching the floor, patient was comfortable without any acute complaints. c-clamp in place at her left femoral access site. past medical history: djd "bladder problems", tx'd with pesserie hypothyroidism denies heart or lung pbs hx scarlet fever as a child . cardiac risk factors: -diabetes, +dyslipidemia, -hypertension . no hx cabg, pci, pacemaker/icd social history: pt lives with her daughter. denies etoh, tob, drugs. family history: there is no family history of premature coronary artery disease or sudden death. both parents and siblings have lived to old age physical exam: vs - 98.3 160/70 75 18 98% ra gen: wdwn middle aged woman in nad. oriented x3. mood, affect appropriate. heent: ncat. sclera anicteric. perrl, eomi. conjunctiva were pink, no pallor or cyanosis of the oral mucosa. no xanthalesma. neck: supple with jvp of 7 cm. cv: pmi located in 5th intercostal space, midclavicular line. rr, normal s1, s2. no m/r/g. no thrills, lifts. no s3 or s4. chest: no chest wall deformities, scoliosis or kyphosis. resp were unlabored, no accessory muscle use. ctab, no crackles, wheezes or rhonchi. abd: soft, ntnd. no hsm or tenderness. abd aorta not enlarged by palpation. no abdominial bruits. ext: no c/c/e. no femoral bruits left hematoma where left femoral entry site was. right femoral entry site intact. skin: no stasis dermatitis, ulcers, scars, or xanthomas neuro: cns intact, motor funx grossly intact . pulses: right: 2+ dp 2+ pt 2+ left: 2+ dp 2+ pt 2+ pertinent results: 07:15am blood wbc-5.9 rbc-3.35* hgb-10.5* hct-30.4* mcv-91 mch-31.3 mchc-34.5 rdw-14.8 plt ct-213 01:00am blood wbc-7.9 rbc-3.87* hgb-12.0 hct-35.1* mcv-91 mch-30.9 mchc-34.1 rdw-13.3 plt ct-258 07:15am blood pt-13.2 ptt-43.8* inr(pt)-1.1 05:50am blood pt-13.0 ptt-26.9 inr(pt)-1.1 07:15am blood glucose-86 urean-14 creat-0.6 na-136 k-4.4 cl-104 hco3-28 angap-8 01:00am blood glucose-99 urean-20 creat-0.8 na-135 k-4.5 cl-102 hco3-26 angap-12 01:00am blood ck-mb-5 ctropnt-<0.01 07:15am blood calcium-8.8 phos-3.1 mg-2.1 01:00am blood calcium-8.7 phos-3.1 mg-2.0 micro: 3:33 am mrsa screen source: nasal swab. **final report ** mrsa screen (final ): no mrsa isolated. radiology: radiology report femoral vascular us left port study date of 2:31 pm findings: -scale and doppler images of the left common femoral vein and artery were obtained. there is normal wall-to-wall flow in the visible vein and artery. a small hypoechoic region anterior to the common femoral artery likely represents the area of the thrombosed pseudoaneurysm. no recurrence is noted. impression: no recurrence of left common femoral pseudoaneurysm. ecg , e f 89 cardiology report ecg study date of 8:45:58 am sinus rhythm with baseline artifact. compared to the previous tracing of both abnormalities are as previously reported without overall diagnostic change. tracing #4 radiology report unilat lower ext veins left study date of 10:52 am findings: there is an approximately 2 cm left common femoral artery pseudoaneurysm. after discussion with the patient and description of the risks and benefits, the left inguinal area was prepped and draped in a sterile fashion. under ultrasound guidance, a 20-gauge spinal needle was advanced into the periphery of this patient's pseudoaneurysm after which approximately 500 units of topical thrombin were injected. there was complete thrombosis of the pseudoaneurysm and persistent patency of the underlying common femoral artery and vein. the patient's peripheral exam on the left did not change after thrombin injection. assessment for lower extremity deep venous thrombosis was also requested. duplex and color doppler demonstrated normal augmentation, compressibility and flow involving the common femoral, superficial femoral, popliteal and proximal tibial veins on the left. impression: 1. left common femoral artery pseudoaneurysm successfully treated with 500 units of topical thrombin without complication. 2. no evidence of left lower extremity dvt. cardiac cath: , e f 89 cardiology report cardiac cath study date of *** not signed out *** brief history: 89 year old female with prior cardiac work-up in preparation for tkr. underwent diagnostic cath at revealing 90% distal lmain disease. given history of chest discomfort at rest, and comorbidities is forward on for pci with impella support. indications for catheterization: known left main coronary disease. triple vessel coronary disease. procedure: bilateral femoral access was obtained in preparation for percutaneous coronary intervention with impella device. with assistance of micropuncture technique, 6f right femoral arterial access, and 8f venous access were obtained. a 5fr pigtail catheter was inserted through the right femoral arterial access and was positioned in the distal aorta. power injection aortogram revealed no significant disease of the distal aorta or iliofemoral system on either side. left femoral access was obtained via micropuncture. it was then preclosed with 2 6fr perclose devices, and the sheath was upsized to the 13fr impella sheath. access to the left ventricle was obtained via pigtail catheter and j wire. this was then exchanged for the impella wire. the impella was prepped and inserted into the lv under fluoroscopic guidance. conscious sedation: was provided with appropriate monitoring performed by a member of the nursing staff. technical factors: total time (lidocaine to test complete) = 3 hours 35 minutes. arterial time = 3 hours 15 minutes. fluoro time = 23 minutes. contrast injected: non-ionic low osmolar (isovue, optiray...), vol 165 mls - midazolam 0.5 mg iv fentanyl 75 mcg iv anesthesia: 1% lidocaine subq. anticoagulation: heparin angiomax units iv other medication: asa bivalirudin 163 complications: hematoma cardiac cath supplies used: - , prowater 300cm - , choice pt extra support 300cm - , choice pt intermediate 300cm 2.5mm , maverick 20mm 3.0mm , maverick 20mm 6fr cordis, xblad 3.5 6fr cordis, jr 4 sh - , perclose proglide - allegiance, custom sterile pack - merit, left heart kit - , priority pack 20/30 3.0mm , promus otw 23mm - abiomed, impella 2.5 attending of record: , j. referring physician: , . fellow: , s. invasive attending staff: , j. , s. brief hospital course: this 89-year-old female presented for pci with des 3.0x 23 mm in distal left main with impella, ostial 80% occluded successfully ptca and ptca rca (90% occluded). post-procedure, she was started on aspirin and clopidogrel. following her successful procedure, she had impaired hemostasis at left femoral entry after perclose device deployment. after the closure she continued to bleed from her left groin and direct pressure was applied for 45 minutes continuously; after 45 minutes pressure was released and vigorous bleeding continued; pressure was again applied for 1 hour, however bleeding continued after pressure was released. by , she dropped her hematocrit from 35.1 on admission to 27.2 and received 1 unit of prbc. post procedure there was evidence of a small left hematoma of the left femoral entry site and a left groin ultrasound was ordered to assess for pseudoaneurysm. ultrasound identified a left common femoral pseudoaneurysm and this was then successfully treated with 500 units of topical thrombin without complication by ir. she then developed delirium which was noticeable mostly at night and at atimes was agitated and required only very rare sedation with very low dose haloperidol. by the morning of she had pulled out her urinary catheter and was then incontinent but became more oriented. there was no evidence of uti or other organic cause found for her delirium. she was more oriented by the morning of and following her blood transfusion, her hematocrit remained stable. metoprolol was started and tolerated well. a repeat femoral vascular us prior to discharge revealed no re-occurrence of the l femoral artery pseudoaneurysm. she was transferred to the cardiology on and her confusion settled. by discharge, she was oriented. brief hospital course by problem: # bleeding and pseudoaneurysm at femoral site access: following successful ptca, mrs had prolonged bleeding from her left groin site but which eventually settled following direct pressure. her hct dropped from 35.1 on admission to 27.2 and received 1 unit of prbc and after this her hb and hct remained stable. a vascular u/s demonstrated a pseudoaneurysm and this was successfully injected with thrombin by ir. there was no furtehrbleeding and repeat femoral vascular us revealed no re-occurrence of the l femoral artery pseudoaneurysm. her hct was stable prior to discharge. . #. cad: diagnostic cardiac catheterisation with impella was performed on demonstrated significant 3-vessel disease with a moderate 60% rca lesion, tight 99% lesion in rca, left main with 90% lesion at the bifurcation of l circ and lad and an 80% lesion in lad after ostium. she had pci with des to lmca and bms of lcx. she was continued on aspirin 325mg qd and clopidogrel. her statin was also changed to atorvastatin 80mg at night. there were no abnormalities in cardiac markers and she had no chest pain whilst an inpatient. . # delirium: she developed delirium which was noticeable at night (during the day she was generally lucid). there was no cause found for her confusion and cultures and wbc were unremarkable. her confusion settled and she was lucid by time of discharge. . # hypertension: due initially to low bps, her amlodipine was held and metoprolol was started. by discharge her bp had settled and he was sent home on metoprolol succinate 50mg qd and amlodipine. . # hypothyroidism: levothyroxine was continued. medications on admission: 1. levothyroxine 88 mcg daily 2. amlodipine 5 mg daily 3. mvi 4. vit b, e 5. vit c 500 mcg 6. vit d 800 units 7. glucosamine, unknown dose discharge medications: 1. levothyroxine 88 mcg tablet sig: one (1) tablet po daily (daily). 2. cholecalciferol (vitamin d3) 1,000 unit tablet sig: one (1) tablet po once a day. 3. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 4. metoprolol succinate 50 mg tablet sustained release 24 hr sig: one (1) tablet sustained release 24 hr po once a day. disp:*30 tablet sustained release 24 hr(s)* refills:*2* 5. acetaminophen 325 mg tablet sig: two (2) tablet po tid (3 times a day). 6. ascorbic acid 500 mg tablet sig: one (1) tablet po daily (daily). 7. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). disp:*90 tablet(s)* refills:*3* 8. atorvastatin 80 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 9. amlodipine 5 mg tablet sig: one (1) tablet po daily (daily). 10. glucosamine oral 11. atorvastatin 80 mg tablet sig: one (1) tablet po once a day. disp:*90 tablet(s)* refills:*3* 12. metoprolol succinate 50 mg tablet sustained release 24 hr sig: one (1) tablet sustained release 24 hr po once a day. disp:*90 tablet sustained release 24 hr(s)* refills:*3* discharge disposition: home with service facility: discharge diagnosis: coronary artery disease left femoral psuedoaneurysm s/p injection hypertension hypothyroidism discharge condition: mental status: confused - sometimes. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: you had a cardiac catheterization with a impella ventricular assist device and a drug eluting stent was placed in your left main coronary artery. you also had blockages in your right coronary artery and left anterior descending artery that was opened with a balloon procedure but no stents were placed. after the procedure you had a bleed in your right groin that needed to be injected to stop bleeding. you needed one unit of blood. now your blood counts are stable. you will need to watch your right groin closely and call dr. right away if you have increased bleeding, pain or swelling in this area. no driving for 3 days, no working in your garden until after you see dr . . we made the following changes in your medications: 1. start plavix 75 mg daily. do not miss or stop taking plavix unless dr. tells you to. this is very important to prevent the stent from clotting off and causing a major heart attack. 2. increase aspirin to 325 mg daily 3. stop taking vitamin e 4. start taking atorvastatin (lipitor) to prevent further blockages in your arteries. 5. increase vitamin d to 1000mg daily 6. start metoprolol to prevent a heart attack and slow your heart rate. followup instructions: pcp :thursday, at 10:15am wilt: ,md location: medical associates address: , , phone: cardiology appointment: , at 12:30 name: a., md location: bldg, address: , , phone: procedure: coronary arteriography using two catheters left heart cardiac catheterization injection or infusion of other therapeutic or prophylactic substance insertion of drug-eluting coronary artery stent(s) cranial or peripheral nerve graft insertion of one vascular stent excision of lingual thyroid percutaneous transluminal coronary angioplasty [ptca] procedure on two vessels insertion of percutaneous external heart assist device diagnoses: coronary atherosclerosis of native coronary artery intermediate coronary syndrome unspecified essential hypertension acute posthemorrhagic anemia unspecified acquired hypothyroidism other and unspecified hyperlipidemia hemorrhage complicating a procedure peripheral vascular complications, not elsewhere classified cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute on chronic systolic heart failure delirium due to conditions classified elsewhere osteoarthrosis, unspecified whether generalized or localized, lower leg aneurysm of artery of lower extremity 

Answer: The patient is high likely exposed to